{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:19:28Z","timestamp":1793089168100,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jhep.2021.01.018","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T18:59:12Z","timestamp":1621796352000},"page":"S14-S26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"S1","title":["New clinical and pathophysiological perspectives defining the trajectory of cirrhosis"],"prefix":"10.1016","volume":"75","author":[{"given":"Rajiv","family":"Jalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-3881","authenticated-orcid":false,"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-0716","authenticated-orcid":false,"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jhep.2021.01.018_bib1","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-Chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a peoposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib5","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","author":"Arroyo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study","author":"Trawal\u00e9","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.018_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhep.2021.01.018_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/lt.20030","article-title":"Is minimal hepatic encephalopathy completely reversible following liver transplantation?","volume":"10","author":"Rose","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.01.018_bib10","doi-asserted-by":"crossref","unstructured":"Trebicka J, Fern\u00e1ndez J, Papp M, Caraceni P, Laleman W, Gambino C, et\u00a0al. The Predict study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology. J Hepatol 2020;73:842-854.","DOI":"10.1016\/j.jhep.2020.06.013"},{"key":"10.1016\/j.jhep.2021.01.018_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D\u2019Amico","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib12","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages in cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D\u2019Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.01.018_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural History of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastro Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib14","article-title":"Ordinal outcomes are superior to binary outcomes for designing and evaluating clinical trials in compensated cirrhosis","author":"D'Amico","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management: 2016 practice guidance by the American Association for the Study of the Liver","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib16","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdinamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib20","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"B-blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2021.01.018_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2017.02.003","article-title":"Non-invasive evaluation of portal hypertension using ultrasound elastography","volume":"67","author":"Berzigotti","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib23","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increases mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal Failure and cirrhosis: a Systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2021.01.018_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.27795","article-title":"Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults","volume":"62","author":"Shi","year":"2015","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.jhep.2021.01.018_bib26","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A\u00a0morphometric and immunoistochemical study to assess the benefit of sustained virological response in hepatitis c virus patients with cirrhosis","volume":"56","author":"D\u2019Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib28","first-page":"295","article-title":"Cirrhosis regression and subclassification","volume":"6","author":"Bedossa","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.jhep.2021.01.018_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.11.007","article-title":"Efficacy of entecavir in treatment-na\u00efve patients with hepatitis B virus-related decompensated cirrhosis","volume":"52","author":"Shim","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12072-018-9914-6","article-title":"Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity-LINA cohort)","volume":"13","author":"Gentile","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2021.01.018_bib31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/BF01072457","article-title":"Resistant ascites in alcoholic liver cirrhosis: course and prognosis","volume":"23","author":"Capone","year":"1978","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.jhep.2021.01.018_bib32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jhep.2020.05.050","article-title":"Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension","volume":"73","author":"Lens","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension. Report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"De Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guideline on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib35","article-title":"Outcomes and mortality of grade 1 ascites and recurrent ascites in patients with cirrhosis","author":"Tonon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0002-9343(72)90188-X","article-title":"Quantitation of portosystemic shunting from the splenic and mesenteric vein in alcoholic liver disease","volume":"53","author":"Groszmann","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib37","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of portal hypertension: how changes in the paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01995065","article-title":"Die Eck\u2019scche fistel zeischen der unteren hohlene und der pfortader und inre folgen f\u00fcr den organismus","volume":"32","author":"Hahn","year":"1893","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"10.1016\/j.jhep.2021.01.018_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01824322","article-title":"Ueber die bestimmung des amoniaks in thierischen fluessigkeiten und geweben","volume":"36","author":"Nencki","year":"1895","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"10.1016\/j.jhep.2021.01.018_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1113\/jphysiol.1896.sp000596","article-title":"On the absorption of fluids from the connective tissue spaces","volume":"19","author":"Starling","year":"1896","journal-title":"J\u00a0Physiol (Lond)"},{"key":"10.1016\/j.jhep.2021.01.018_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11011-014-9494-7","article-title":"Cerebral effects of ammonia in liver disease: current hypothesis","volume":"29","author":"Ott","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2021.01.018_bib42","first-page":"102","article-title":"Astrocytic control of biosynthesis and turnover of the neurotransmitters glutamate and GABA","volume":"4","author":"Schousboe","year":"2013","journal-title":"Front Endrocrinol"},{"key":"10.1016\/j.jhep.2021.01.018_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1011614528751","article-title":"Neurotransmitter dysfunction in hepatic encephalopathy","volume":"16","author":"Butterworth","year":"2001","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2021.01.018_bib44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.27282","article-title":"Novel insights into ammonia-mediated neurotoxicity pointing to potential new therapeutic strategies","volume":"60","author":"Hadjihambi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1471-4159.2009.05981.x","article-title":"Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline","volume":"109","author":"Jiang","year":"2009","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.jhep.2021.01.018_bib46","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jhep.2016.07.046","article-title":"Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy","volume":"65","author":"Weiss","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib47","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis.; TRIBE-AKI Consortium","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2021.01.018_bib51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cgh.2016.09.157","article-title":"Hepatic encephalopathy is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures","volume":"15","author":"Bajaj","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib53","first-page":"1732","article-title":"Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine","volume":"58","author":"Ru\u00edz-del-\u00c1rbol","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.29520","article-title":"Cardiovascular predictors of death in patients with cirrhosis","volume":"68","author":"Cesari","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib55","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0016-5085(03)01207-1","article-title":"Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis","volume":"125","author":"Schenk","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib56","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.gastro.2008.06.038","article-title":"Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates","volume":"135","author":"Fallon","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib57","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: mayo clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2021.01.018_bib58","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/lt.21174","article-title":"Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol","volume":"13","author":"Fix","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.01.018_bib59","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib60","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cgh.2019.09.035","article-title":"Including relative adrenal insufficiency in definition and classification of acute-on-chronic liver failure","volume":"18","author":"Piano","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib61","first-page":"750","article-title":"Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction","volume":"78","author":"Kabadi","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.018_bib62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2265.1995.tb02040.x","article-title":"Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation","volume":"43","author":"Handelsman","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jhep.2021.01.018_bib63","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2014.02.026","article-title":"Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography","volume":"60","author":"Durand","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib64","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2020.03.029","article-title":"Changes in frailty are associated with waitlist mortality in patients with cirrhosis","volume":"73","author":"Lai","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005792-197105000-00002","article-title":"Spontaneous bacterial peritonitis: variations on a theme","volume":"50","author":"Conn","year":"1971","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2021.01.018_bib66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/gut.18.7.556","article-title":"Functional renal failure and haemorragic gastritis associated with endotoxaemia in cirrhosis","volume":"18","author":"Clemente","year":"1977","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.018_bib67","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib68","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib69","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/jhep.2000.17687","article-title":"The systemic inflammatory response syndrome and acute liver failure","volume":"32","author":"Rolando","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib70","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis. From the peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension. The undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib72","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/hep.21599","article-title":"Endotoxemia produces coma and brain swelling in bile duct ligated rats","volume":"45","author":"Wright","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib73","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00018-005-5089-0","article-title":"The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation","volume":"62","author":"Shawcross","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jhep.2021.01.018_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","article-title":"Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis","volume":"40","author":"Shawcross","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/nyas.13985","article-title":"Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury","volume":"1437","author":"Meneses","year":"2019","journal-title":"Ann NY Acad"},{"key":"10.1016\/j.jhep.2021.01.018_bib76","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12035-016-0356-7","article-title":"Blood barrier breakdown as a cause and consequence of neuroinflammation in sepsis","volume":"55","author":"Danieslki","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jhep.2021.01.018_bib77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of plasma volume expansi\u00f3n on renal impairment and mortality in patients with cirrhosis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib78","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.018_bib79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic Inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib80","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/hep.23918","article-title":"Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis","volume":"52","author":"Bellot","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib81","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic renal and hepatic hemodynamics derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz del Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib82","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/gut.52.8.1182","article-title":"Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis","volume":"52","author":"Mookerjee","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.018_bib83","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/liv.12559","article-title":"Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure","volume":"35","author":"Mehta","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.018_bib84","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2021.01.018_bib85","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000172","article-title":"Outcome prediction of covert hepatic encephalopathy in liver cirrhosis: comparison of four testing strategies","volume":"11","author":"Labenz","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.018_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146076","article-title":"Clinical and pathophysiological characteristics of cirrhotic patients with grade 1 and minimal hepatic encephalopathy","volume":"11","author":"Thomsen","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2021.01.018_bib87","unstructured":"Tonon M, Rosi S, Gambino CG, Piano S, Calvino V, Romano A. et\u00a0al. The natural history of Acute Kidney Disease (AKD) in patients with cirrhosis. J Hepatol. (in press)."},{"key":"10.1016\/j.jhep.2021.01.018_bib88","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.01.018_bib89","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system\u2019s role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2021.01.018_bib90","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2021.01.018_bib91","doi-asserted-by":"crossref","first-page":"1686-1701","DOI":"10.1002\/hep.30363","article-title":"Orchestration of tryptophan-kynurenine pathway, acute decompensation, and acute-on-chronic liver failure in cirrhosis","volume":"69","author":"Cl\u00e0ria","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib92","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","article-title":"Patients with acute-on-chronic liver failure display \u201csepsis like\u201d immune paralysis\u201d","volume":"42","author":"Wasmuth","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased number of regulatory immune cells expressing the receptor tyrosine kinase MERTK","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib94","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib95","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1136\/gutjnl-2018-316888","article-title":"Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity","volume":"68","author":"Korf","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.018_bib96","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/gutjnl-2017-314184","article-title":"CD14+CD15-HLA-DR-myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure","volume":"67","author":"Bernsmeier","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.018_bib97","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2020.02.017","article-title":"Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis","volume":"73","author":"Weichselbaum","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib98","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","article-title":"The innate immune cells in cirrhosis","volume":"73","author":"Bernsmeier","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib99","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2016.10.012","article-title":"Hepatology snapshot: diagnosis and prognosis of acute-on-chronic liver failure (ACLF) in cirrhosis","volume":"66","author":"Arroyo","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.03.046","article-title":"Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis","author":"L\u00f3pez-Vicario","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib102","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708712","article-title":"Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?","volume":"10","author":"Van Wyngene","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","article-title":"Metabolic regulations in immune responses","volume":"32","author":"Ganeshan","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhep.2021.01.018_bib104","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2019.01.050","article-title":"Energetic trade-offs and hypometabolic states promote disease tolerance","volume":"177","author":"Ganeshan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2021.01.018_bib105","article-title":"An integrated clinic-metabolomic model improves prediction of death in sepsis","volume":"5","author":"Mohney","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3932","article-title":"An evolutionary perspective of immunometabolism","volume":"363","author":"Wang","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jhep.2021.01.018_bib107","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2014.02.014","article-title":"A\u00a0switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advanced liver disease","volume":"60","author":"Nishhikawa","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.018_bib108","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.01.018_bib109","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.018_bib110","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.018_bib111","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.01.018_bib112","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2018.12.007","article-title":"Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation","volume":"156","author":"Sundaram","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:43:09Z","timestamp":1759174989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":112,"alternative-id":["S0168827821000295"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.01.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New clinical and pathophysiological perspectives defining the trajectory of cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}